Zarnestra (tipifarnib)

tipifarnib · Janssen (Johnson & Johnson)

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Zarnestra (tipifarnib), covering 2012-11-09 to 2015-11-17. Get the full timeline:

Most recent: Clinical Trial Update: S9924 R115777 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer [Phase 2]